Identification of gene expression patterns crucially involved in experimental autoimmune encephalomyelitis and multiple sclerosis

Antigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune Diseases

(2015) Christine Riedhammer et al.   Frontiers in Immunology

Diversity and Inter-Connections in the CXCR4 Chemokine Receptor/Ligand Family: Molecular Perspectives

(2015) Lukas Pawig et al.   Frontiers in Immunology

Dual Role of CD38 in Microglial Activation and Activation-Induced Cell Death

(2014) L. Mayo et al.   JOURNAL OF IMMUNOLOGY

The Inflammasome Pyrin Contributes to Pertussis Toxin-Induced IL-1β Synthesis, Neutrophil Intravascular Crawling and Autoimmune Encephalomyelitis

(2014) Aline Dumas et al.   PLoS Pathogens

CD38 Controls the Innate Immune Response against Listeria monocytogenes

(2013) Timo Lischke et al.   INFECTION AND IMMUNITY

The Immune Pathogenesis of Multiple Sclerosis

(2013) Robert Weissert   Journal of Neuroimmune Pharmacology

The SDF-1 3′A Genetic Variation of the Chemokine SDF-1α (CXCL12) in Parallel with its Increased Circulating Levels is Associated with Susceptibility to MS: A Study on Iranian Multiple Sclerosis Patients

(2011) Hossein Azin et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

(2010) Ludwig Kappos et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antagonism of the Chemokine Receptors CXCR3 and CXCR4 Reduces the Pathology of Experimental Autoimmune Encephalomyelitis

(2008) Rachel E. Kohler et al.   BRAIN PATHOLOGY

CXCL12 (SDF-1α) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific regulatory T cells

(2008) Moran Meiron et al.   JOURNAL OF EXPERIMENTAL MEDICINE